Find information on thousands of medical conditions and prescription drugs.

Cri du chat

Cri du chat syndrome, also called deletion 5p syndrome, or 5p minus, is a rare genetic disorder due to a missing portion of chromosome 5. It was first described by Jérôme Lejeune in 1963. The condition affects an estimated 1 in 20,000 to 50,000 live births. The disorder is found in people of all ethnic backgrounds and is slightly more common in females. more...

Home
Diseases
A
B
C
Angioedema
C syndrome
Cacophobia
Café au lait spot
Calcinosis cutis
Calculi
Campylobacter
Canavan leukodystrophy
Cancer
Candidiasis
Canga's bead symptom
Canine distemper
Carcinoid syndrome
Carcinoma, squamous cell
Carcinophobia
Cardiac arrest
Cardiofaciocutaneous...
Cardiomyopathy
Cardiophobia
Cardiospasm
Carnitine transporter...
Carnitine-acylcarnitine...
Caroli disease
Carotenemia
Carpal tunnel syndrome
Carpenter syndrome
Cartilage-hair hypoplasia
Castleman's disease
Cat-scratch disease
CATCH 22 syndrome
Causalgia
Cayler syndrome
CCHS
CDG syndrome
CDG syndrome type 1A
Celiac sprue
Cenani Lenz syndactylism
Ceramidase deficiency
Cerebellar ataxia
Cerebellar hypoplasia
Cerebral amyloid angiopathy
Cerebral aneurysm
Cerebral cavernous...
Cerebral gigantism
Cerebral palsy
Cerebral thrombosis
Ceroid lipofuscinois,...
Cervical cancer
Chagas disease
Chalazion
Chancroid
Charcot disease
Charcot-Marie-Tooth disease
CHARGE Association
Chediak-Higashi syndrome
Chemodectoma
Cherubism
Chickenpox
Chikungunya
Childhood disintegrative...
Chionophobia
Chlamydia
Chlamydia trachomatis
Cholangiocarcinoma
Cholecystitis
Cholelithiasis
Cholera
Cholestasis
Cholesterol pneumonia
Chondrocalcinosis
Chondrodystrophy
Chondromalacia
Chondrosarcoma
Chorea (disease)
Chorea acanthocytosis
Choriocarcinoma
Chorioretinitis
Choroid plexus cyst
Christmas disease
Chromhidrosis
Chromophobia
Chromosome 15q, partial...
Chromosome 15q, trisomy
Chromosome 22,...
Chronic fatigue immune...
Chronic fatigue syndrome
Chronic granulomatous...
Chronic lymphocytic leukemia
Chronic myelogenous leukemia
Chronic obstructive...
Chronic renal failure
Churg-Strauss syndrome
Ciguatera fish poisoning
Cinchonism
Citrullinemia
Cleft lip
Cleft palate
Climacophobia
Clinophobia
Cloacal exstrophy
Clubfoot
Cluster headache
Coccidioidomycosis
Cockayne's syndrome
Coffin-Lowry syndrome
Colitis
Color blindness
Colorado tick fever
Combined hyperlipidemia,...
Common cold
Common variable...
Compartment syndrome
Conductive hearing loss
Condyloma
Condyloma acuminatum
Cone dystrophy
Congenital adrenal...
Congenital afibrinogenemia
Congenital diaphragmatic...
Congenital erythropoietic...
Congenital facial diplegia
Congenital hypothyroidism
Congenital ichthyosis
Congenital syphilis
Congenital toxoplasmosis
Congestive heart disease
Conjunctivitis
Conn's syndrome
Constitutional growth delay
Conversion disorder
Coprophobia
Coproporhyria
Cor pulmonale
Cor triatriatum
Cornelia de Lange syndrome
Coronary heart disease
Cortical dysplasia
Corticobasal degeneration
Costello syndrome
Costochondritis
Cowpox
Craniodiaphyseal dysplasia
Craniofacial dysostosis
Craniostenosis
Craniosynostosis
CREST syndrome
Cretinism
Creutzfeldt-Jakob disease
Cri du chat
Cri du chat
Crohn's disease
Croup
Crouzon syndrome
Crouzonodermoskeletal...
Crow-Fukase syndrome
Cryoglobulinemia
Cryophobia
Cryptococcosis
Crystallophobia
Cushing's syndrome
Cutaneous larva migrans
Cutis verticis gyrata
Cyclic neutropenia
Cyclic vomiting syndrome
Cystic fibrosis
Cystinosis
Cystinuria
Cytomegalovirus
Dilated cardiomyopathy
Hypertrophic cardiomyopathy
Restrictive cardiomyopathy
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Medicines

Signs and symptoms

Its name, meaning cat cry in French, is from the distinctive mewing sound made by infants with the disorder. As babies, patients tend to be squirmy with a mewing cry, ascribed to abnormal laryngeal development. The cry becomes less distinctive with age. Individuals with cri du chat syndrome are often underweight at birth. The disorder is characterized by distinctive facial features, small head size (microcephaly), low birth weight, weak muscle tone (hypotonia), a round face, epicanthal folds, low set ears, strabismus, facial asymmetry and downward slanting palpebral fissures. Cardiac malformations may occur and affect the vital prognosis. The importance of the whole syndrome seems to vary depending on the amount of lost DNA material.

In terms of development and behaviour, severe mental retardation is typical. Expressive language is an area of weakness, and signing is often used. Hypersensitivity to noise is common. Also, some have autistic traits such as repetitive behaviors and obsessions with certain objects. Apparently, many enjoy pulling hair. They are often happy children, and are described as "loving" and sociable.

Genetics

Cri du chat syndrome is due to a partial deletion of the short arm of chromosome number 5. Approximately 85% of cases results from a sporadic de novo deletion, while about 15% are due to unequal segregation of a parental chromosome translocation. Although the size of the deletion varies, a deletion at region at 5p15.3 is responsible for the unique cry and the critical region of 5p15.2 is responsible for the other features. The deletion is of paternal origin in about 80% of cases in which the syndrome is de novo. Genetic counseling and genetic testing may be offered to families with cri du chat syndrome.

Read more at Wikipedia.org


[List your site here Free!]


Screening chromosome ends for learning disability - Editorial
From British Medical Journal, 11/18/00 by Samantha J L Knight

Small chromosomal rearrangements may be behind idiopathic learning disability

Learning disability affects about 3% of the population, yet the cause remains unknown in about 40% of people with moderate to severe learning disability (IQ [is less than] 50) and in 70% of people with mild developmental delay (IQ 50-75).[1] It is estimated that between 30% and 50% of cases of undiagnosed learning disability may be genetic in origin.[2] Mapping and sequencing the human genome have provided new ways of looking for chromosomal abnormalities. The standard investigation for learning disability is to stain chromosomes to reveal their unique banding pattern and then to look for any anomalies using light microscopy. However, the resolution of this routine cytogenetic approach is limited since very small rearrangements are not visible and larger abnormalities escape notice if they occur in regions where the banding pattern is not distinctive. There have been many attempts to increase reliability and resolution, but there is still no practical way to screen the entire human genome for rearrangements, regardless of size or chromosomal location. However, an alternative to whole genome screening, which has transformed our diagnostic capabilities, is to focus on specific chromosomal regions, in particular the chromosome ends, known as telomeres.

Some years ago molecular investigation of the chromosomal disorders implicated in learning disability established that cytogenetically undetectable rearrangements involving telomeres could give rise to Wolf-Hirschhorn syndrome (chromosome 4p), cri du chat syndrome (chromosome 5p), Miller-Dieker syndrome (chromosome 17p), and [Alpha] thalassaemia with learning disability (ATR-16 chromosome 16p).[3-7] However, only recently has the full extent of the involvement of small telomeric rearrangements in learning disability been appreciated. A novel method of molecular screening that looks at every chromosome end was used on over 400 children with idiopathic learning disability and established that 7.4% of those with moderate to severe learning disability had subtle abnormalities of chromosome ends.[8 9] If we take into account all known causes of disability in children with moderate to severe learning disability, then rearrangements of chromosome ends account for a total of 3% and are the second most common cause after Down's syndrome.

Making a diagnosis is important in caring for the child and it is important for the family and society. There is a need for a straightforward, cost effective service for screening for telomeres provided by clinical diagnostic laboratories, and for guidelines on who should be screened. The cost of the Chromoprobe T System (Cytocell Ltd) seems acceptable at 125 [pounds sterling] ($168) for a full telomeric screening test, but the budget of many clinical genetics centres is not enough to cover the potential demand if every child with idiopathic learning disability were to be screened. Although increased demand may encourage companies to lower prices, the burden of cost can also be relieved by better defining who should be investigated for small chromosomal deletions.

In half the cases the disorder is familial--that is, one parent is found to be carrying a balanced chromosomal rearrangement. Thus, although the hit rate for finding a telomeric abnormality is 8% when the test is used for routine screening, subsequent investigation of first and second degree relatives increases the number of diagnoses to about 25% of people tested.[9]

A more cost effective strategy would be to identify a clinical subgroup in which small rearrangements at telomeres occur at a much higher frequency. Unfortunately, however, there are no characteristic clinical features that would help. In a study by Knight et al a combination of facial dysmorphism, minor physical abnormalities of hands or feet, small stature, and microcephaly were present in almost all those found to have chromosomal rearrangement. However, this constellation of features is common to many people with developmental delay.[9] One definite indication for testing is the observation of either a similar, or dissimilar, phenotype in a relative; a normal parent with a balanced translocation between two different chromosomes may pass on different unbalanced chromosomes to his or her affected children, thus creating the possibility of dissimilar features in related individuals. Until further studies are reported and clinical subcategories better defined, we advocate investigating telomeres in all patients with moderate to severe learning disability who have the clinical features described, especially those who have other affected family members.

[1] Flint J, Wilkie AO. The genetics of mental retardation. Br Med Bull 1996; 52:453-64.

[2] Fryns JP, Volcke PH, Haspeslagh M, Beusen L, Van Den Berghe H. A genetic diagnostic survey of an institutionalized population of 262 moderately retarded patients: the Borgerstein experience. J Ment Defic Res 1990;34:29-40.

[3] Lamb J, Wilkie AOM, Harris PC, Buckle VJ, Lindenhaum RH, Barton NJ, et al. Detection of breakpoints in submicroscopic chromosomal translocation, illustrating an important mechanism for genetic disease. Lancet 1989;ii:819-24.

[4] Overhauser J, Bengtsson U, McMahon J, Ulm J, Butler MG, Santiago L, et al. Prenatal-diagnosis and carrier detection of a cryptic translocation by using DNA markers from the short arm of chromosome 5. Am J Hum Genet 1989;45:296-303.

[5] Altherr MR, Bengtsson U, Elder FFB, Ledbetter DH, Wasmuth JJ, McDonald ME, et al. Molecular confirmation of Wolf-Hirschhorn syndrome with a subtle translocation of chromosome 4. Am J Hum Genet 1991;49:1235-42.

[6] Flint J, Wilkie AO, Buckle VJ, Winter, RM, Holland AJ, McDermid HE. The detection of subtelomeric chromosomal rearrangements in idiopathic mental retardation. Nat Genet 1995;9:132-40.

[7] Kuwano A, Ledbetter SA, Dobyns WB, Emanuel BS, Ledbetter DH. Detection of deletions and cryptic translocations in Miller-Dieker syndrome by in situ hybridization. Am J Hum Genet 1991;49:707-14.

[8] Knight SJL Horsley SW, Regan R, Lawrie NM, Maher EJ, Cardy DLN, et al. Development and clinical application of an innovative fluorescence in situ hybridization technique which detects submicroscopic rearrangements involving telomeres. Eur J Hum Genet 1997;5:1-8.

[9] Knight SJL, Regan R, Nicod A, Horsley SW, Kearney L, Homfray T, et al. Subtle chromosomal rearrangements in children with unexplained mental retardation. Lancet 1999;354:1676-81.

Samantha J L Knight Wellcome Trust research fellow

Jonathan Flint consultant psychiatrist

Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DS

BMJ 2000;321:1240

We ask all editorial writers to sign a declaration of competing interests (bmj.com/guides/ confli.shtml#aut). We print the interests only when there are some. When none are shown, the authors have ticked the "None declared" box.

COPYRIGHT 2000 British Medical Association
COPYRIGHT 2000 Gale Group

Return to Cri du chat
Home Contact Resources Exchange Links ebay